Repligen (RGEN) Announces New 5-Year Supply Agreement for recombinant Protein A with GE Healthcare (GE)
Tweet Send to a Friend
Repligen Corporation (Nasdaq: RGEN) has extended its longstanding relationship with GE Healthcare Bio-Sciences AB (NYSE: GE) by entering into a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
